“AmplifyBio is cutting costs, closing its R&D and characterization services site in South San Francisco and laying off employees in its Ohio-based preclinical CRO business, a company spokesperson confirmed to Fierce Biotech in an email.”
All entries for: AmplifyBio
December 9, 2024
AmplifyBio
Layoffs
West Jefferson, OH
201-500 employees
Disease Area: Cardiology, Neurological Diseases, Respiratory Diseases
Drug Type: Biologic, Small Molecule